Avenue Therapeutics, Inc. (ATXI) Financials
ATXI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.0 million | 1.4 million |
| March 31, 2026 | 2.5 million | 1.3 million |
| Dec. 31, 2025 | 2.9 million | 1.1 million |
| Sept. 30, 2025 | 3.7 million | 1.4 million |
ATXI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -475000 | 61000 |
| March 31, 2026 | -438000 | 61000 |
| Dec. 31, 2025 | -854000 | 142000 |
| Sept. 30, 2025 | 383000 | 163000 |
ATXI Net Income
No data available :(
ATXI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.9 million | - | - |
| March 31, 2026 | 2.4 million | - | - |
| Dec. 31, 2025 | 2.9 million | - | - |
| Sept. 30, 2025 | 3.7 million | - | - |
ATXI Shares Outstanding
ATXI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 247000 | 460000 | - |
| March 31, 2026 | - | 200000 | 514000 | - |
| Dec. 31, 2025 | - | 257000 | 697000 | - |
| Sept. 30, 2025 | - | 177000 | 547000 | - |
ATXI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
ATXI
Price: $0.26
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246300
Market Capitalization: 848783